What foods use Red Dye No. 3? What to know about the newly banned food coloring
The Food and Drug Administration has said it is banning the use of Red No. 3, a synthetic dye that has long been used in the ...
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic ...
verywellhealth15d
Zepbound Gets FDA Approval to Treat Sleep Apnea
The FDA removed Zepbound from its drug shortage list this week for the first time since its approval last year. However, some worry that the move could affect people who rely on cheaper generic ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Hosted on MSN20d
FDA Approves Tryngolza as Adjunct to Diet for Familial Chylomicronemia Syndrome
FRIDAY, Dec. 27, 2024 (HealthDay News) -- Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ... The FDA approval was based on data ...
Everyday Health20d
FDA Approves First Medication for Obstructive Sleep Apnea
The FDA approved Zepbound (tirzepatide ... “This is the first drug treatment for obstructive sleep apnea, and so that’s exciting, and it provides a good opportunity to help the care of ...
Medical Xpress21d
FDA approves first generic liraglutide once-daily injection
The approval of the once-daily injection (18 mg/3 mL), as an adjunct to diet ... the FDA's continued commitment to advancing patient access to safe, effective, and high-quality generic drug ...
Yahoo Finance21d
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
The drug will be available in early January, and will be priced at parity with the list price of the IV version, Adam Lenkowsky, Bristol's chief commercialization officer, told Reuters ahead of the ...
The Globe and Mail21d
U.S. FDA approves injectable version of cancer drug from Bristol Myers Squibb
The IV version of the drug has a list price of $7,635 per infusion for two weeks for the lower dose and $15,269 per infusion for four weeks for the higher 480-milligram dose. The approval was ...
Scientific American21d
The FDA Is Changing What Foods Can Be Called ‘Healthy’
who worked for 15 years in the Office of Regulatory Policy in the FDA’s Center for Drug Evaluation and Research. “FDA is updating the criteria for ‘healthy’ claims on food labels in line ...